Clues to quality of journals
Open Access Policy of Helmholtz Association 2016
CC Licencences
Publication Metrics
Home
Deutsch
New EVA Application
Advanced Search
Browse by ...
Publication overview
Statistics (last 5 years)
OA Publications
Submit Publication
Import publication from...
Report missing publication
Contact persons
Help
Text
Endnote (RIS)
BibTeX
DOI
 |
|
Open Access Green as soon as Postprint is submitted to ZB.
The triumvirate of beta-cell regeneration: Solutions and bottlenecks to curing diabetes.
Int. J. Dev. Biol. 62, 453-464 (2018)
On 11 January 1922 insulin injection was used for the first time in the treatment of diabetes. Even today, daily insulin injections are the life-saving treatment for patients with Type 1 diabetes and advanced Type 2 diabetes. However, insulin injections often fail to achieve full glucose control, which in the long-term leads to multiple complications and mortality. Beta-cells, the natural producers and secretors of insulin, remain the gold-standard in regulating blood glucose levels. In this review, we focus on three strategies aiming at counteracting beta-cell loss in order to gain insulin independence: replacement, replication and protection. The three approaches, together termed as the triumvirate of beta-cell regeneration, may constitute the basis for a future cure for diabetes.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Times Cited
Scopus
Cited By
Cited By
Altmetric
1.579
0.657
3
4
Annotations
Special Publikation
Hide on homepage
Publication type
Article: Journal article
Document type
Review
Keywords
Reprogramming ; Regeneration ; Protection ; Diabetes; Insulin-producing Cells; In-vivo; Centroacinar Cells; Secreting Cells; Stem-cells; Mass; Endocrine; Islets; Liver; Differentiation
Language
english
Publication Year
2018
HGF-reported in Year
2018
ISSN (print) / ISBN
0214-6282
e-ISSN
1696-3547
Quellenangaben
Volume: 62,
Issue: 6-8,
Pages: 453-464
Publisher
University of the Basque Country Press (UBC Press)
Publishing Place
Po Box 1397, Bilbao, Bizkaia E-48080, Spain
Reviewing status
Peer reviewed
Institute(s)
Institute of Pancreatic Islet Research (IPI)
POF-Topic(s)
90000 - German Center for Diabetes Research
Research field(s)
Helmholtz Diabetes Center
PSP Element(s)
G-502600-010
WOS ID
WOS:000451691600013
Erfassungsdatum
2018-12-20